Nutra Pharma Corp. (NPHC)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 7, 2025, 8:00 PM EDT
Nutra Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2013 - 2017 |
---|---|---|---|---|---|---|
Period Ending | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2013 - 2017 |
Cash & Equivalents | - | 0.09 | - | - | - | Upgrade |
Cash & Short-Term Investments | - | 0.09 | - | - | - | Upgrade |
Accounts Receivable | 0.02 | 0.05 | 0.04 | 0.03 | 0.02 | Upgrade |
Other Receivables | - | 0.01 | 0 | - | - | Upgrade |
Receivables | 0.25 | 0.33 | 0.04 | 0.03 | 0.02 | Upgrade |
Inventory | 0.02 | 0.03 | 0.01 | 0.01 | 0.04 | Upgrade |
Prepaid Expenses | 0.06 | 0.07 | 0.01 | 0.01 | 0.01 | Upgrade |
Other Current Assets | - | 0.02 | - | 0.01 | 0.05 | Upgrade |
Total Current Assets | 0.33 | 0.53 | 0.06 | 0.06 | 0.12 | Upgrade |
Property, Plant & Equipment | 0.33 | 0.14 | 0.16 | 0.21 | 0.01 | Upgrade |
Other Long-Term Assets | 0.09 | 0.11 | 0.09 | 0.07 | 0.02 | Upgrade |
Total Assets | 0.75 | 0.78 | 0.3 | 0.34 | 0.14 | Upgrade |
Accounts Payable | 0.73 | 0.67 | 0.6 | 0.58 | 0.48 | Upgrade |
Accrued Expenses | 3.04 | 2.05 | 2.39 | 2.02 | 2.02 | Upgrade |
Short-Term Debt | 8.04 | 3.28 | 2.26 | 6.09 | 2.11 | Upgrade |
Current Portion of Long-Term Debt | 0 | 4.52 | 2.59 | 1.39 | 1.42 | Upgrade |
Current Portion of Leases | 0.07 | 0.08 | 0.08 | 0.07 | - | Upgrade |
Current Unearned Revenue | 0.18 | - | - | - | - | Upgrade |
Other Current Liabilities | 0.63 | 10.54 | 3.57 | 0.84 | 0 | Upgrade |
Total Current Liabilities | 12.7 | 21.14 | 11.48 | 10.99 | 6.03 | Upgrade |
Long-Term Debt | 0.25 | 0.52 | 0.25 | 0.91 | 0.05 | Upgrade |
Long-Term Leases | 0.18 | - | 0.06 | 0.14 | - | Upgrade |
Total Liabilities | 13.13 | 21.66 | 11.8 | 12.04 | 6.08 | Upgrade |
Common Stock | 7.04 | 7.33 | 6.96 | 5.88 | 4.05 | Upgrade |
Additional Paid-In Capital | 53.65 | 53.51 | 50.18 | 50.28 | 51.29 | Upgrade |
Retained Earnings | -73.55 | -81.73 | -68.63 | -67.86 | -61.27 | Upgrade |
Comprehensive Income & Other | 0.47 | - | - | - | - | Upgrade |
Total Common Equity | -12.39 | -20.89 | -11.5 | -11.7 | -5.94 | Upgrade |
Shareholders' Equity | -12.38 | -20.88 | -11.49 | -11.7 | -5.94 | Upgrade |
Total Liabilities & Equity | 0.75 | 0.78 | 0.3 | 0.34 | 0.14 | Upgrade |
Total Debt | 8.55 | 8.4 | 5.24 | 8.6 | 3.58 | Upgrade |
Net Cash (Debt) | -8.55 | -8.3 | -5.24 | -8.6 | -3.58 | Upgrade |
Net Cash Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade |
Filing Date Shares Outstanding | 7,100 | 7,364 | 7,268 | 7,260 | 6,855 | Upgrade |
Total Common Shares Outstanding | 7,040 | 7,331 | 6,955 | 5,877 | 4,047 | Upgrade |
Working Capital | -12.37 | -20.61 | -11.43 | -10.93 | -5.91 | Upgrade |
Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade |
Tangible Book Value | -12.39 | -20.89 | -11.5 | -11.7 | -5.94 | Upgrade |
Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade |
Machinery | - | 0.19 | 0.15 | 0.14 | 0.14 | Upgrade |
Leasehold Improvements | - | 0.07 | 0.07 | 0.07 | 0.07 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.